Early and Sustained Treatment Satisfaction Observed in Patients With Moderate to Severe Psoriasis Treated With Ixekizumab: Results From Second Interim Analysis of the Real-World Psoriasis in Special Areas (PSoSA) Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 1, p. s509, 2025. DOI: 10.25251/skin.9.supp.509. Disponível em: https://skin.dermsquared.com/skin/article/view/3154. Acesso em: 13 apr. 2025.